New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement

ARKGvsPTHETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.14%
VS
ETF 2
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-0.03%

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, PTH's top sector exposures are Health Care  ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.72% for PTH. ARKG is up 2.44% year-to-date (YTD) with -$37M in YTD flows. PTH performs worse with 1.75% YTD performance, and -$6M in YTD flows. Run a side-by-side ETF comparison of ARKG and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs PTH performance and flow charts

Performance

0510152025%Mar 27Apr 6Apr 13Apr 20Apr 27

Cumulative Flows

-80,000,000-60,000,000-40,000,000-20,000,000020,000,000Mar 27Apr 6Apr 13Apr 20Apr 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/27/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
PTH
+19.74%+8.86%
-7.79%+4.25%
+2.44%+1.75%
+33.74%+32.72%
+3.79%+30.38%
-67.31%-2.01%
Flows
ARKG
PTH
-$22M-$498K
-$94M-$5M
-$37M-$6M
-$81M-$10M
-$609M-$80M
-$3.04B-$357M
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
PTH
+42.80%+27.25%
+41.55%+23.02%
+42.57%+24.62%
+45.35%+25.29%
Max drawdown
ARKG
PTH
-23.56%-7.51%
-27.52%-11.91%
-51.98%-29.24%
-80.16%-50.10%
Max drawdown duration
ARKG
PTH
90d40d
95d140d
1013d271d
1763d1699d
Trading data

Create an account to view trading data

Join for free
ARKG
PTH
Last sale
4/29/2026 at 1:30 PM
$28.53
$49.66
Previous close
04/28/2026
$29.58
$50.57
Consolidated volume
04/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
ARKG
PTH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/29/2026 at 1:30 PM
Live
Closed
ARKG
PTH
Last price
$28.53
$49.66
1D performance
-3.55%
-1.80%
AuM$1.16 B$121.40 M
E/R0.75%0.72%
Characteristics
ARKG
PTH
Management strategyActivePassive
ProviderArk InvestmentInvesco
Benchmark-Dorsey Wright Healthcare Technical Leaders Index
N° of holdings2746
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019October 12, 2006
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
70.4%
Switzerland
9.23%
Other
20.37%
PTH
USA
94.53%
Other
5.47%

Sectors

ARKG
Health Care
78.38%
Other
21.62%
PTH
Health Care
85.2%
Other
14.8%

Diversification

ARKG

Total weight of top 15 holdings out of 15

62.5%
PTH

Total weight of top 15 holdings out of 15

52.67%

Top 15 holdings

Data as of March 31, 2026
ARKG
CRISPR THERAPEUTICS
9.23%
10X GENOMICS INC
6.30%
BEAM THERAPEUTICS
4.86%
PERSONALIS INC
4.69%
NATERA
4.48%
ILLUMINA
4.45%
GUARDANT HEALTH INC
4.21%
INTELLIA THERAPEUTICS INC
3.58%
CAREDX INC/D
3.56%
RECURSION PHARMACEUTICALS
3.54%
ABSCI
3.27%
VERACYTE INC/D
2.98%
ADAPTIVE BIOTECHNOLOGIES
2.71%
NURIX THERAPEUTICS
2.45%
SEMA4 HOLDINGS CORP
2.19%
PTH
TERNS PHARMACEUTICALS
6.73%
ROIVANT SCIENCES LTD
5.47%
US74006W2070
5.15%
ARROWHEAD PHARMACEUTICALS INC
3.66%
GUARDANT HEALTH INC
3.47%
REVOLUTION MEDICINES INC
3.32%
TENET HEALTHCARE
3.16%
UTD THERAPEUT
2.99%
NATERA
2.95%
HCA HEALTHCARE
2.89%
CELCUITY INC
2.88%
AXSOME THERA CMN STK
2.58%
MADRIGAL PHARMACEUTICALS INC
2.58%
PROTAGONIST THERAPEUTICS INC
2.43%
COGENT BIOSCIENCES
2.40%
Frequently asked questions about ARKG and PTH

How have the ARKG and PTH ETFs performed in 2026?

As of April 27, 2026, ARKG is up 2.44% year-to-date (YTD), while PTH has returned 1.75%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or PTH?

Year-to-date, the ARKG ETF saw -$37M in flows, compared to -$6M for PTH.

Which ETF is more volatile: ARKG or PTH?

Over the past year, ARKG had a volatility of 41.55%, while PTH experienced 23.02%.

Which ETF is bigger: ARKG or PTH?

As of April 27, 2026, ARKG holds $1.16 B in assets under management (AUM), while PTH manages $121.40 M.

What sectors do the ARKG and PTH ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, PTH focuses on Health Care.

What are the top holdings of the ARKG ETF and PTH ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. PTH holds in its top three: TERNS PHARMACEUTICALS, ROIVANT SCIENCES LTD and US74006W2070.

Which ETF is more diversified: ARKG or PTH?

ARKG holds 27 securities with 62.5% of its assets in the top 15. PTH has 57 securities and a top 15 weight of 52.67%.

Advertisement
Latest news about ARKG & PTH
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast